메뉴 건너뛰기




Volumn 1, Issue 1, 1999, Pages 82-88

Papillomavirus virus-like particles as anticancer vaccines

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; VIRUS PROTEIN;

EID: 0032913307     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (24)

References (60)
  • 1
    • 0030577120 scopus 로고    scopus 로고
    • Papillomavirus Infections - A major cause of human cancers
    • zur Hausen H: Papillomavirus Infections - a major cause of human cancers. Biochem Biophys Acta (1996) 1288:F55-78.
    • (1996) Biochem Biophys Acta , vol.1288
    • Zur Hausen, H.1
  • 2
    • 0027050013 scopus 로고
    • Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly Immunogenic
    • Kimbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles Into virus-like particles that are highly Immunogenic. Proc Natl Acad Sci USA (1992) 89:12180-12184.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 12180-12184
    • Kimbauer, R.1    Booy, F.2    Cheng, N.3    Lowy, D.R.4    Schiller, J.T.5
  • 3
    • 0028120905 scopus 로고
    • Interaction of human Papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an Intact L2 N-terminal sequence
    • Zhou J, Sun XY, Louis K, Frazer IH: Interaction of human Papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an Intact L2 N-terminal sequence. J Virol (1994) 68:619-625.
    • (1994) J Virol , vol.68 , pp. 619-625
    • Zhou, J.1    Sun, X.Y.2    Louis, K.3    Frazer, I.H.4
  • 6
    • 0028300962 scopus 로고
    • Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids
    • Hagensee ME, Olson NH, Baker TS, Galloway DA: Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol (1994) 68:4503-4505.
    • (1994) J Virol , vol.68 , pp. 4503-4505
    • Hagensee, M.E.1    Olson, N.H.2    Baker, T.S.3    Galloway, D.A.4
  • 8
    • 0027397943 scopus 로고
    • Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
    • Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 67:315-322.
    • (1993) J Virol , vol.67 , pp. 315-322
    • Hagensee, M.E.1    Yaegashi, N.2    Galloway, D.A.3
  • 9
    • 0027930718 scopus 로고
    • Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
    • Christensen ND, Hopfi R, DiAngelo SL, Cladel NM, Patrick SD, Welsh, PA, Budgeon LR, Reed CA, Kreider JW: Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol (1994) 75:2271-2276.
    • (1994) J Gen Virol , vol.75 , pp. 2271-2276
    • Christensen, N.D.1    Hopfi, R.2    DiAngelo, S.L.3    Cladel, N.M.4    Patrick, S.D.5    Welsh, P.A.6    Budgeon, L.R.7    Reed, C.A.8    Kreider, J.W.9
  • 10
    • 0025331023 scopus 로고
    • Antibody-mediated neutralization in vivo of Infectious papillomaviruses
    • Christensen ND, Kreider JW: Antibody-mediated neutralization In vivo of Infectious papillomaviruses. J Virol (1990) 64:3151-3156.
    • (1990) J Virol , vol.64 , pp. 3151-3156
    • Christensen, N.D.1    Kreider, J.W.2
  • 11
    • 0029841214 scopus 로고    scopus 로고
    • In vitro generation and type-specific neutralization of a human papillomavirus type 16 virlon pseudotype
    • Roden RB, Greenstone HL, Kimbauer R, Booy FP, Jessie J, Lowy DR, Schiller JT: In vitro generation and type-specific neutralization of a human papillomavirus type 16 virlon pseudotype. J Virol (1996) 70:5875-5883. This paper demonstrates that neutralization of an HPV-16 pseudovirion is dependent on type-specific antibodies.
    • (1996) J Virol , vol.70 , pp. 5875-5883
    • Roden, R.B.1    Greenstone, H.L.2    Kimbauer, R.3    Booy, F.P.4    Jessie, J.5    Lowy, D.R.6    Schiller, J.T.7
  • 12
    • 0031905637 scopus 로고    scopus 로고
    • In vitro Infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
    • White WI, Wilson SD, Bonnez W, Rose RC, Koenig S, Suzich JA: In vitro Infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 72:959-964. This paper demonstrates that authentic HPV virions can be neutralized with antibodies induced by HPV-16 VLPs and neutralization is type-restricted.
    • (1998) J Virol , vol.72 , pp. 959-964
    • White, W.I.1    Wilson, S.D.2    Bonnez, W.3    Rose, R.C.4    Koenig, S.5    Suzich, J.A.6
  • 15
    • 0029025444 scopus 로고
    • Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV Infection
    • Breitburd F, Kimbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, Schiller JT, Lowy DR: Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV Infection. J Virol (1995) 69:3959-3963. Immunization with CRPV VLPs protects against papillomas and carcinoma induced by CRPV, and protection is mediated by antibodies to L1 conformational epitopes.
    • (1995) J Virol , vol.69 , pp. 3959-3963
    • Breitburd, F.1    Kimbauer, R.2    Hubbert, N.L.3    Nonnenmacher, B.4    Trin-Dinh-Desmarquet, C.5    Orth, G.6    Schiller, J.T.7    Lowy, D.R.8
  • 16
    • 0028845930 scopus 로고
    • Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-lnduced papilloma formation
    • Jansen KU, Rosolowsky M, Schultz LD, Markus HZ, Cook JC, Donnelly JJ, MarBnez D, Ellis RW, Shaw AR: Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-lnduced papilloma formation. Vaccine (1995) 13:1509-1514. Immunization with CRPV VLPs protects against papillomas induced by CRPV.
    • (1995) Vaccine , vol.13 , pp. 1509-1514
    • Jansen, K.U.1    Rosolowsky, M.2    Schultz, L.D.3    Markus, H.Z.4    Cook, J.C.5    Donnelly, J.J.6    MarBnez, D.7    Ellis, R.W.8    Shaw, A.R.9
  • 17
    • 0030048139 scopus 로고    scopus 로고
    • Immunization with virus-like particles Induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
    • Christensen ND, Reed CA, Qadel NM, Han R, Kreider JW: Immunization with virus-like particles Induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol (1996) 70:960-965. Strong and long-lasting protection against challenge with CRPV is achieved with immunization with CRPV VLPs.
    • (1996) J Virol , vol.70 , pp. 960-965
    • Christensen, N.D.1    Reed, C.A.2    Qadel, N.M.3    Han, R.4    Kreider, J.W.5
  • 20
    • 0031950209 scopus 로고    scopus 로고
    • Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined Immunodeficiency mouse
    • Bonnez W, DaRin C, Borkhuis C, de Mesy Jensen K, Relehman RC, Rose RC. Isolation and propagation of human papillomavirus type 16 In human xenografts implanted In the severe combined Immunodeficiency mouse. J Virol (1998) 72:5256-5261. HPV16 virions are propagated from human foreskin fragments impianted in SCID mice. Passage of the virus caused SIL-like lesions.
    • (1998) J Virol , vol.72 , pp. 5256-5261
    • Bonnez, W.1    DaRin, C.2    Borkhuis, C.3    De Mesy Jensen, K.4    Relehman, R.C.5    Rose, R.C.6
  • 21
    • 0028888363 scopus 로고
    • Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies
    • Hagensee ME, Carter JJ, Wipf GC, Galloway DA: Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology (1995) 206:174-182.
    • (1995) Virology , vol.206 , pp. 174-182
    • Hagensee, M.E.1    Carter, J.J.2    Wipf, G.C.3    Galloway, D.A.4
  • 23
    • 0031668082 scopus 로고    scopus 로고
    • Nasal Immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
    • Balmeili C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D: Nasal Immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies In mucosal secretions. J Virol (1998) 72:8220-8229. Long-lasting titers of IgA and IgG anti-HPV16 VLP antibodies are found in saliva and genital secretions after nasal immunization of mice.
    • (1998) J Virol , vol.72 , pp. 8220-8229
    • Balmeili, C.1    Roden, R.2    Potts, A.3    Schiller, J.4    De Grandi, P.5    Nardelli-Haefliger, D.6
  • 24
    • 0029845430 scopus 로고    scopus 로고
    • Virus-like particles Induce MHC class 1-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen
    • Schirmbeck R, Bohm W, Reimann J: Virus-like particles Induce MHC class 1-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology (1996) 39:111-119.
    • (1996) Intervirology , vol.39 , pp. 111-119
    • Schirmbeck, R.1    Bohm, W.2    Reimann, J.3
  • 25
    • 0029801019 scopus 로고    scopus 로고
    • Genetically engineered particulate virus-like structures and their use as vaccine delivery systems
    • Roy P: Genetically engineered particulate virus-like structures and their use as vaccine delivery systems. Intervirology (1996) 39:62-71.
    • (1996) Intervirology , vol.39 , pp. 62-71
    • Roy, P.1
  • 26
    • 10544230643 scopus 로고    scopus 로고
    • Synthesis and assembly of chlmeric human Immunodeficiency virus gag pseudovirions
    • Tobin GJ, Li GH, Williamson JC, Nagashima K, Gonda MA: Synthesis and assembly of chlmeric human Immunodeficiency virus gag pseudovirions. Intervirology (1996) 39:40-48.
    • (1996) Intervirology , vol.39 , pp. 40-48
    • Tobin, G.J.1    Li, G.H.2    Williamson, J.C.3    Nagashima, K.4    Gonda, M.A.5
  • 27
    • 0030273342 scopus 로고    scopus 로고
    • MHC class I-restricted CTL responses to exogenous antigens
    • Jondal M, Schirmbeck R, Reimann J: MHC class I-restricted CTL responses to exogenous antigens. Immunity (1996) 5:295-302.
    • (1996) Immunity , vol.5 , pp. 295-302
    • Jondal, M.1    Schirmbeck, R.2    Reimann, J.3
  • 28
    • 0030795494 scopus 로고    scopus 로고
    • Recombinant parvovirus-llke particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxlc T-cells
    • Sedlik C, Saron M, Sarraseca J, Casal I, Leclerc C: Recombinant parvovirus-llke particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxlc T-cells. Proc Natl Acad Sci USA (1997) 94:7503-7508.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 7503-7508
    • Sedlik, C.1    Saron, M.2    Sarraseca, J.3    Casal, I.4    Leclerc, C.5
  • 31
    • 0028316949 scopus 로고
    • Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB Interactions
    • Von Knebel Doeberitz M, Rittmuller C, Aengeneyndt F, Jansen-Durr P, Spitkovsky D: Reversible repression of papillomavirus oncogene expression In cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB Interactions. J Virol (1994) 68:2811-2821.
    • (1994) J Virol , vol.68 , pp. 2811-2821
    • Von Knebel Doeberitz, M.1    Rittmuller, C.2    Aengeneyndt, F.3    Jansen-Durr, P.4    Spitkovsky, D.5
  • 33
    • 0032484471 scopus 로고    scopus 로고
    • Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway
    • Peng S, Frazer IH, Fernando GJ, Zhou J: Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 240:147-157.
    • (1998) Virology , vol.240 , pp. 147-157
    • Peng, S.1    Frazer, I.H.2    Fernando, G.J.3    Zhou, J.4
  • 37
    • 0028811410 scopus 로고
    • Early phase in the Infection of cultured cells with papillomavirus virions
    • Zhou J, Gissmann L, Zentgraf H, Müller H, Picken M, Müller M: Early phase In the Infection of cultured cells with papillomavirus virions. Virology (1995) 214:167-176. Electron microscopic and immunofluorescence data showing that capsid proteins of bovine papillomavirus virions and BPV VLPs are found In the nucleus of Infected cells, then degraded and deposited In the Golgi apparatus.
    • (1995) Virology , vol.214 , pp. 167-176
    • Zhou, J.1    Gissmann, L.2    Zentgraf, H.3    Müller, H.4    Picken, M.5    Müller, M.6
  • 38
    • 0028850506 scopus 로고
    • Processing of exogenous heat-aggregated (denatured) and partlculate (native) hepatitis B surface antigen for class -restricted epltope presentation
    • Schlrmbeck R, Bohm W, Melber K, Relmann J: Processing of exogenous heat-aggregated (denatured) and partlculate (native) hepatitis B surface antigen for class (-restricted epltope presentation. J Immunol (1995) 155:4676-4684.
    • (1995) J Immunol , vol.155 , pp. 4676-4684
    • Schlrmbeck, R.1    Bohm, W.2    Melber, K.3    Relmann, J.4
  • 40
    • 0031127553 scopus 로고    scopus 로고
    • Cell mediated Immunity Induced in mice by HPV 16 L1 virus-like particles
    • Dupuy C, Buzoni-Gatel D, Touze A, Le Cann P, Bout D, Coursaget P: Cell mediated Immunity Induced In mice by HPV 16 L1 virus-like particles. Microbial Pathogenesis (1997) 22:219-225. Data are presented which demonstrate that VLPs Induce cellular Immunity In addition to previously described humoral Immunity.
    • (1997) Microbial Pathogenesis , vol.22 , pp. 219-225
    • Dupuy, C.1    Buzoni-Gatel, D.2    Touze, A.3    Le Cann, P.4    Bout, D.5    Coursaget, P.6
  • 42
    • 0032566921 scopus 로고    scopus 로고
    • L1-specific protection from tumor challenge elicited by HPV16 virus-like particles
    • De Bruijn ML, Greenstone HL, Vermeulen H, Melief CJM, Lowy DR, Schiller JT, Kast WM: L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology (1998) 250:371-376. This paper demonstrates that L1 protein of HPV16 expressed In an HPV16 genome-transformed cell line can function as a tumor rejection antigen. Immunization is performed with HPV16 L1 VLPs.
    • (1998) Virology , vol.250 , pp. 371-376
    • De Bruijn, M.L.1    Greenstone, H.L.2    Vermeulen, H.3    Melief, C.J.M.4    Lowy, D.R.5    Schiller, J.T.6    Kast, W.M.7
  • 46
    • 0028231616 scopus 로고
    • Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation
    • Tindle RW, Frazer IH: Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. Curr Topics Microbiol Immunol (1994) 186:217-253.
    • (1994) Curr Topics Microbiol Immunol , vol.186 , pp. 217-253
    • Tindle, R.W.1    Frazer, I.H.2
  • 47
    • 2442751256 scopus 로고    scopus 로고
    • Crucial role of vaccine delivery system and Immune suppressed state in cervical cancer patients undergoing treatment with therapeutic vaccines
    • Stem PL, Carroll M, Beverly PCL (Eds), Cambridge University Press, Cambridge, in press
    • Rudolf MP, Small LA, Velders MP, Da Silva DM, Weljzen S, Kast WM: Crucial role of vaccine delivery system and Immune suppressed state In cervical cancer patients undergoing treatment with therapeutic vaccines. In: Cancer Vaccinas: Strategies, Prospects and Realities of Immune Intervention. Stem PL, Carroll M, Beverly PCL (Eds), Cambridge University Press, Cambridge, in press.
    • Cancer Vaccinas: Strategies, Prospects and Realities of Immune Intervention
    • Rudolf, M.P.1    Small, L.A.2    Velders, M.P.3    Da Silva, D.M.4    Weljzen, S.5    Kast, W.M.6
  • 48
    • 0029935569 scopus 로고    scopus 로고
    • Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL Induced by peptide vaccination can lead to the inability to reject tumors
    • Toes REM, Blom RJJ, Offringa R, Kast WM, Melief CJM: Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL Induced by peptide vaccination can lead to the inability to reject tumors. J Immunol (1996) 156:3911-3918.
    • (1996) J Immunol , vol.156 , pp. 3911-3918
    • Toes, R.E.M.1    Blom, R.J.J.2    Offringa, R.3    Kast, W.M.4    Melief, C.J.M.5
  • 49
    • 0029798058 scopus 로고    scopus 로고
    • Peptide vaccination can lead to enhance tumor growth through specific T-cell tolerance Induction
    • Toes REM, Offringa R, Blom RJJ, Melief CJM, Kast WM: Peptide vaccination can lead to enhance tumor growth through specific T-cell tolerance Induction. Proc Natl Acad Sci USA (1996) 93:7855-7860.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 7855-7860
    • Toes, R.E.M.1    Offringa, R.2    Blom, R.J.J.3    Melief, C.J.M.4    Kast, W.M.5
  • 51
    • 0030068375 scopus 로고    scopus 로고
    • Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
    • Un KY, Guarnleri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC: Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 56:21-26.
    • (1996) Cancer Res , vol.56 , pp. 21-26
    • Un, K.Y.1    Guarnleri, F.G.2    Staveley-O'Carroll, K.F.3    Levitsky, H.I.4    August, J.T.5    Pardoll, D.M.6    Wu, T.C.7
  • 52
    • 0027985363 scopus 로고
    • Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T-lymphocytes against mouse tumor P815
    • Van den Eynde B, Mazarguil H, Lethe B, Laval F, Gairin JE: Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T-lymphocytes against mouse tumor P815. Eur J Immunol (1994) 24:2740-2745.
    • (1994) Eur J Immunol , vol.24 , pp. 2740-2745
    • Van den Eynde, B.1    Mazarguil, H.2    Lethe, B.3    Laval, F.4    Gairin, J.E.5
  • 54
    • 0032030315 scopus 로고    scopus 로고
    • In vitro gene transfer using human papillomavirus-like particles
    • Touze A, Coursaget P: In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 26:1317-1323. Data are presented which demonstrate that VLPs can package unrelated plasmid DNA in vitro and deliver foreign DNA to eukaryotic cells with subsequent gene expression.
    • (1998) Nucleic Acids Res , vol.26 , pp. 1317-1323
    • Touze, A.1    Coursaget, P.2
  • 55
    • 0031058283 scopus 로고    scopus 로고
    • Antisense targeting of E6AP elevates p53 in HPV-Infectod cells but not in normal cells
    • Beer-Romero P, Glass S, Rolfe M: Antisense targeting of E6AP elevates p53 In HPV-Infectod cells but not in normal cells. Oncogens (1997) 14:595-602.
    • (1997) Oncogens , vol.14 , pp. 595-602
    • Beer-Romero, P.1    Glass, S.2    Rolfe, M.3
  • 57
    • 0031569119 scopus 로고    scopus 로고
    • Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation
    • Cayeux S, Richter G, Noffz G, Dorken B, Blankenstein T: Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J Immunol (1997) 158:2834-2841.
    • (1997) J Immunol , vol.158 , pp. 2834-2841
    • Cayeux, S.1    Richter, G.2    Noffz, G.3    Dorken, B.4    Blankenstein, T.5
  • 58
    • 0027538181 scopus 로고
    • Vaccination with Irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
    • Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with Irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA (1993) 90:3539-3543.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 3539-3543
    • Dranoff, G.1    Jaffee, E.2    Lazenby, A.3    Golumbek, P.4    Levitsky, H.5    Brose, K.6    Jackson, V.7    Hamada, H.8    Pardoll, D.9    Mulligan, R.C.10
  • 59
    • 0029025421 scopus 로고
    • Binding and Internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
    • Volpers C, Unckell F, Schirmacher P, Streeck RE, Sapp M: Binding and Internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 69:3258-3264.
    • (1995) J Virol , vol.69 , pp. 3258-3264
    • Volpers, C.1    Unckell, F.2    Schirmacher, P.3    Streeck, R.E.4    Sapp, M.5
  • 60
    • 0031469159 scopus 로고    scopus 로고
    • Immunomanipulative strategies for the control of human papillomavirus associated cervical disease
    • Tindle RW: Immunomanipulative strategies for the control of human papillomavirus associated cervical disease. Immunologic Res (1997) 16:387-400.
    • (1997) Immunologic Res , vol.16 , pp. 387-400
    • Tindle, R.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.